Curis’s stock rises as analysts see ‘the next Pharmacyclics’
November 17, 2023 at 09:04 AM EST
Shares of Curis rose premarket Friday as analysts see biotech company as potential take-out target
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.